未找到相关数据
KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience
被引：119
作者：
Van Cutsem, E.
Lang, I.
D'haens, G.
Moiseyenko, V.
Zaluski, J.
Folprecht, G.
Tejpar, S.
Kisker, O.
Stroh, C.
Rougier, P.
机构：
[1] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[2] Natl Inst Oncol, Budapest, Hungary
[3] Imelda Ziekenhuis, Bonheiden, Belgium
[4] NN Petrov Res Inst Oncol Biotherapy & Bone Marrow, St Petersburg, Russia
[5] Wielkopolskie Ctr Onkol, Poznan, Poland
[6] Univ Hosp Carl Gustav Carus Dresden, Dresden, Germany
[7] Univ Hosp Gasthuiberg, Louvain, Belgium
[8] Merck Serono, Frankfurt, Germany
[9] Merck Serono, Darmstadt, Germany
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页数：1
相关论文